SCHEMBL16448706

SCHEMBL16448706

CC(C)(C)OC(=O)c1cc(Cl)c(COC2CCCCC2)cc1F

nearest known ligand 0.64

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 18/20 0.64
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15536853 0.83 SCN9A (0.68) SCN9ANPC1RAB9ASMN1; SMN2
SCHEMBL17244937 0.79 SCN9A (0.36) SCN9A
SCHEMBL16448571 0.78 SCN9A (1.00) SCN9A
SCHEMBL17240727 0.78 SCN9A (0.38) SCN9A
SCHEMBL15544550 0.78 SCN9A (0.36) SCN9A
SCHEMBL15036521 0.76 SCN9A (0.38) SCN9ASMN1; SMN2MAPT
SCHEMBL15535576 0.75 SCN9A (0.64) SCN9A
SCHEMBL16448572 0.75 SCN9A (1.00) SCN9A
SCHEMBL16759102 0.74 MGLL (0.41) SCN9A
SCHEMBL15036608 0.74 SCN9A (0.60) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed